Healthcare of Today Acquires Macuclear

Healthcare of Today, Inc. today announces that it has completed the acquisition of MacuCLEAR, Inc., a specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye.

MacuCLEAR’s (www.macuclear.com) groundbreaking work leverages its unique understanding of ocular pharmacology and drug development to advance a pipeline of proprietary pharmaceuticals. MC-1101, MacuCLEAR’s primary product compound, is a patented, preservative-free drug delivered with a proprietary delivery system for treating and stopping the progression of dry Age-related Macular Degeneration (AMD). MacuCLEAR has an active IND for MC-1101 and has completed a successful Phase Ib/Proof of Concept human clinical trial.

http://www.marketwire.com/press-release/Healthcare-Today-Acquires-Pharmaceutical-Company-Treating-Dry-Age-Related-Macular-Degeneration-1158393.htm

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: